Back to AMGN
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Upcoming Catalysts
What are catalysts?Competitive Landscape
0 competitors in Neovascular (Wet) Age-related Macular Degeneration (AMD)
View Full LandscapeDrug Information
Target Indication
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Clinical Trial
NCT04270747Last updated: 1/9/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
